Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2007
08/08/2007CN101011439A Collunarium or spraying preparation for treating nasal cavity inflammation and its preparation method
08/08/2007CN101011436A Medical usage of total phytosterone from achyranthes
08/08/2007CN101011435A Shanxiangyuan leaf extract, preparation method and uses thereof
08/08/2007CN101011433A Medicinal liquor for treating skin disease and trauma
08/08/2007CN101011424A Composition with anti-oxidation and metabolism-promotion functions
08/08/2007CN101011420A Preparing process and usage of grease of housefly larva and fatty acid thereof
08/08/2007CN101011414A Improved lung-brain composition medicine
08/08/2007CN101011412A Usage of low-molecular-weight algal polysaccharide sulfate in preparation of medicament for treating hepatic disease
08/08/2007CN101011411A Usage of algal polysaccharide sulfate in preparation of medicament for treating hepatic disease
08/08/2007CN101011410A Animal-used compound preparation for treating virosis of livestock and fowl and preparation method thereof
08/08/2007CN101011409A Collunarium containing vitamin B12
08/08/2007CN101011408A Animal-used compound preparation for treating parasitic disease in or out of livestock and fowl body and preparation method thereof
08/08/2007CN101011407A Amphotericin B liposome antigungal eye drops and its preparation method
08/08/2007CN101011406A Composition used as gynaecologic externally used agent
08/08/2007CN101011405A Pharmaceutical composition for treating ischemic cerebral vascular disease
08/08/2007CN101011404A Use of caudatin-3-O-beta-D-cymaroside as medicament for treating tumour
08/08/2007CN101011403A Pharmaceutical composition of adefovir dipivoxil and its preparation method
08/08/2007CN101011402A Compound sulfadimidine sodium injection and its preparation method
08/08/2007CN101011401A Application of carbenoxolone in preparation of medicine for treating cerebral vasospasm
08/08/2007CN101011400A Piroxicam self-emulsifying pharmaceutical transmission system and its preparation method
08/08/2007CN101011399A Use of tetrandrine as chemotherapy pharmaceutical sensitivity agent for treating gastric cancer
08/08/2007CN101011398A Amodiaquine hydrochloride coating particle and its preparation
08/08/2007CN101011397A Pantoprazole sodium freeze dried injection and preparation method thereof
08/08/2007CN101011396A Sustained release microcapsule of licardipine hydrochloride and its preparing process
08/08/2007CN101011395A Sustained release preparation of licardipine hydrochloride and its preparing process
08/08/2007CN101011394A Pharmaceutical composition for injection containing faropenem
08/08/2007CN101011393A Irbesartan gastric retention sustained-release pharmaceutical composition
08/08/2007CN101011392A Amino acid composition for enhancing traumatic organism growth factor expression and oxidation resistance function
08/08/2007CN101011391A Clonidine paster for treating children's hyperkinetic symptom, twitch symptom and its preparation method
08/08/2007CN101011390A Use of angiotensin II receptor antagonists for treating acute myocardial infarction
08/08/2007CN101011389A Application of arbidol in preparing medicaments for preventing and/or treating hepatitis B
08/08/2007CN101011388A Chewing tablet with vision fatigue relieving function
08/08/2007CN101011387A Soft capsule of coumarin derivative and its preparation method
08/08/2007CN101011386A Dropping pill of coumarin derivative and its preparation and application
08/08/2007CN101011385A Pharmaceutical composition of coumarin derivative and its preparation and application
08/08/2007CN101011384A Pharmaceutical composition with antiphlogistic, antitussive and apophlegmatic function and its preparing process
08/08/2007CN101011383A Dispersible tablet of coumarin derivative and its preparation method
08/08/2007CN101011382A Oral preparation of bilobalide with high bioavailability and preparation method thereof
08/08/2007CN101011381A Stomach floating tablet of bilobalide and preparation method thereof
08/08/2007CN101011380A Use of taspine for preparing medicament for inhibiting tumor angiogenesis
08/08/2007CN101011379A Use of piperic acid ethyl ester in preparation of medicament or healthcare product for preventing and/or treating atherosclerosis
08/08/2007CN101011378A Process for preparing iris aglycone and use thereof in preparation of medicament for treating atherosclerosis
08/08/2007CN101011377A Application of compound s6 in the process for preparing anti-cancer medicament
08/08/2007CN101011376A Self-emulsifying capsule of docetaxel and its preparation method
08/08/2007CN101011375A Combretastatin A-4 eye-using preparation for treating diabetic retinopathy
08/08/2007CN101011374A Non-steroidal analgesic-antipyretic medicament paracetamol containing carboxyl group
08/08/2007CN101011373A Pharmaceutical composition containing L-carnitine and preparation method thereof
08/08/2007CN101011372A Preparing method of alpha-ketoglutaric acid-arginine salt and its use for treating hepatic disease
08/08/2007CN101011371A Pharmaceutical preparation of alpha-ketoglutaric acid, its preparation process and use
08/08/2007CN101011370A Pharmaceutical preparation of alpha-ketoglutaric acid composition, its preparation process and use
08/08/2007CN101011369A Colon-specific ornidazole tablet
08/08/2007CN101011368A Slow release tablet of troxerutin
08/08/2007CN101011367A Slow release tablet of glucurolactone
08/08/2007CN101011366A Slow release tablet of methylphenidate
08/08/2007CN101011365A Slow release tablet of ampicillin
08/08/2007CN101011364A Slow release preparation of metformin rosiglitazone
08/08/2007CN101011363A Slow release tablet of amoxicillin
08/08/2007CN101011362A Dispersible tablet of pidotimod and its preparing process and use
08/08/2007CN101011361A Dispersible tablet of bendazac lysine and its preparation method
08/08/2007CN101011360A Recipe composition of dry turbid agent and its preparation process
08/08/2007CN101011359A Solid liposome nano granule with antineoplastic activity
08/08/2007CN101011358A Nanostructured liposome vector with highly effective antineoplastic activity
08/08/2007CN101011357A Process for preparing Paclitaxel liposome preparation
08/08/2007CN101011356A Aerosol and its preparation
08/08/2007CN101011355A Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
08/08/2007CN101011354A Asarone submicron emulsion and its preparation method
08/08/2007CN101011353A Anti-cancer composition loading both platinum compound and alkylating agent
08/08/2007CN101011351A Anti-cancer composition loading both platinum compound and synergist
08/08/2007CN101011347A Slow release injection containing platinum compound and topoisomerase inhibitor
08/08/2007CN101011345A Slow release injection containing platinum compound and alkylating agent
08/08/2007CN101011173A OPC beverage and its making method
08/08/2007CN101011125A Method for processing instant color bean curd
08/08/2007CN101011107A Pharmaceutical premixed agent for disease resistance and growth promotion and application thereof
08/08/2007CN101011084A Milk for regulating organism immunity and its preparation
08/08/2007CN101011058A Disinfectant and/or bactericidal aqueous compositions
08/07/2007WO2007091338A1 Composition for prevention of recurrence of stroke
08/07/2007USRE39762 e.g. 13-desmethoxy-18-hydroxyl-FK-520; compounds of the invention may be administered to achieve immunosuppression or to stimulate nerve growth and regeneration
08/07/2007US7253319 Disubstituted chalcone oximes having RARγ retinoid receptor antagonist activity
08/07/2007US7253318 e.g. 3-[4-(3-fluoro-benzyloxy)-phenoxy]-propionamidecarbamic acid 2-[4-(3-fluoro-benzyloxy)-phenyl]-ethyl ester; for treatment of acute and/or chronic neurological disorder is mild cognitive impairment or senile dementia; alzheimer's
08/07/2007US7253306 Opening a sultone ring with a nucleophile to produce propanedisulfonic acids and salts, 3-amino-1-propanesulfonic acid and 1,3-propanedisulfonic acid disodium salt with increased purity; byproduct inhibition; treating amyloidosis
08/07/2007US7253302 Mixed esters of dicarboxylic acids for use as pigment dispersants
08/07/2007US7253296 Acylated aminopropanediols and analogues and therapeutic uses thereof
08/07/2007US7253295 Chloride channel opener
08/07/2007US7253294 Saponifying green plant oleoresin to provide a saponified resin, adding a first volatile organic solvent to provide a suspension, removing the solids, condensing the solution to provide an oil; and adding a second volatile organic solvent to solidify the natural product
08/07/2007US7253293 5Z,7E-3 beta ,11 alpha -dihydroxy-9,10-secopregna-5,7,10(19)trien-20-one; from enzymatically hydroxylating the vitamin D3-like compound
08/07/2007US7253290 3-[2,2-dimethyl-3-oxo-3-(7-azabicyclo[2.2.1]heptan-7-yl)propoxy]-4-[(1S)-1-methyl-2-[(isopropoxycarbonyl)imino(-3-pyridin-4-yl-pyrrolidin-1-yl)methyl]aminoethyl]-5-(3,5-dimethylphenyl)-1H-pyrazole; prodrugs for treating prostatic cancer, uterine cancer, breast cancer and pituitary gonadotrophe adenoma
08/07/2007US7253286 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
08/07/2007US7253284 Chemical compounds
08/07/2007US7253283 9-[4-[4-[[2-(2,2,2-trifluoroethoxy)benzoyl]amino]-1-piperidinyl]butyl]-N-(2,2,2-trifluoroethyl)-9H-fluorene-9-carboxamide; non-steroidal modulator of the glucocorticoid receptor, AP-1, and/or NF- kappa B activity, obesity, diabetes, inflammatory and immune diseases
08/07/2007US7253282 Hexafluoroisopropanol substituted cyclohexane derivatives
08/07/2007US7253281 2-(9-bromo-3,4,10,10a-tetrahydro-1H-pyrazino[1,2-a]indol-2-yl)-cyclobutanone; treating disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, obesity and sleep apnea
08/07/2007US7253254 Polypeptide variants with increased heparin-binding capacity
08/07/2007US7253212 Retinol derivative and cosmetic composition comprising the same
08/07/2007US7253211 (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity
08/07/2007US7253210 Contraceptives; hormone sensitive disease; aging resistance; antidepressants; sexual disorders ; osteoporosis; hormone replacement therapy
08/07/2007US7253209 Dissolving in iodinated poppyseed oil fatty ester
08/07/2007US7253208 Tecarfarin, 1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yl 4-((4-hydroxy-2-oxo-2H-chromen-3-yl)methyl)benzoate, or pharmaceutically acceptable salts thereof
08/07/2007US7253207 Quinones as disease therapies
08/07/2007US7253205 Neurokinin 1 (NK-1) receptor antagonists; depression, anxiety, pain, inflammation, migraine, emesis, postherpetic neuralgia
08/07/2007US7253204 Antiproliferative agents